(Q33482104)

English

Phase I study of cyclophosphamide (NSC 26271) by 72-hour continuous intravenous infusion.

scientific article

Statements

Phase I study of cyclophosphamide (NSC 26271) by 72-hour continuous intravenous infusion (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit